Application no. and date | 18779884.8 (espacenet) (Federated) (European Patent Register), 20180907 | Patent/reg. no. and date | DK/EP 3678668, 20240110 | Publication date | 20200715 | Priority no. and date | US 201762556117 P, 20170908 | EP pub. no. and date |
EP 3678668 20200715 | Effective date | | Applicant/owner | The Board of Trustees of the Leland Stanford Junior University, Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386
Stanford, CA 94305-2038, US | Applicant ref. no. | PV1865DKEP | Inventor | SMITH, Mark, 1080 Sutter Street Apt. 401
San Francisco California 94109, US, LI, Lingyin, 1962A Menalto Ave.
Menlo Park California 94025, US, SHAW, Kelsey Erin, 2257 Hanover Street
Palo Alto California 94306, US, CAROZZA, Jacqueline Ann, 31 Angell Ct Apt 106
Stanford California 94305, US, BOEHNERT, Volker, 2257 Hanover St
Palo Alto California 94306, US | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | Opponent | | IPC Class | A61K 31/519 (2006.01) , A61P 35/00 (2006.01) , C07D 471/00 (2006.01) | Title | ENPP1-inhibitorer og deres anvendelse til behandling af kræft | Int. application no. | US2018050018 | Int. publication no. | WO2019051269 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|